Phase 1b/2 Trial of Iberdomide in Combination with Daratumumab, Dexamethasone Plus /-Carfilzomib to Eliminate MRD after Induction Therapy and ASCT in NDMM
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined